Quarry LP Purchases 166 Shares of Chemed Co. (NYSE:CHE)

Quarry LP raised its position in Chemed Co. (NYSE:CHE) by 721.7% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 189 shares of the company’s stock after purchasing an additional 166 shares during the period. Quarry LP’s holdings in Chemed were worth $103,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the company. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Chemed during the first quarter valued at approximately $1,064,000. ProShare Advisors LLC raised its stake in shares of Chemed by 6,288.9% during the 1st quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after purchasing an additional 49,808 shares during the period. Cim LLC bought a new stake in shares of Chemed during the 4th quarter worth $1,328,000. Sei Investments Co. boosted its holdings in shares of Chemed by 4.5% in the 1st quarter. Sei Investments Co. now owns 41,336 shares of the company’s stock worth $26,535,000 after buying an additional 1,780 shares during the last quarter. Finally, American National Bank & Trust Co. VA bought a new position in Chemed during the first quarter valued at about $3,122,000. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

NYSE CHE opened at $592.70 on Wednesday. The company has a market capitalization of $8.97 billion, a PE ratio of 31.90, a price-to-earnings-growth ratio of 2.40 and a beta of 0.44. Chemed Co. has a 52-week low of $497.36 and a 52-week high of $654.62. The company has a 50-day simple moving average of $575.72 and a 200 day simple moving average of $575.12.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The firm had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. During the same quarter in the previous year, the company posted $4.71 EPS. Chemed’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, analysts forecast that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 annualized dividend and a yield of 0.34%. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio (DPR) is 10.76%.

Insider Activity at Chemed

In other Chemed news, Director George J. Walsh III sold 200 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the transaction, the director now owns 3,446 shares in the company, valued at $1,991,615.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the sale, the chief executive officer now owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the transaction, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The disclosure for this sale can be found here. In the last three months, insiders have sold 9,144 shares of company stock worth $5,264,839. Company insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.